milrinone has been researched along with 15-hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic acid in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (8.33) | 18.7374 |
| 1990's | 5 (41.67) | 18.2507 |
| 2000's | 6 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alousi, AA; Evans, DB; Grant, AM; Harris, AL; Silver, PJ | 1 |
| Barradas, MA; Jagroop, A; Jeremy, JY; Mikhailidis, DP; O'Donoghue, S | 1 |
| Levy, JH; Salmenperä, M | 1 |
| Ahmad, A; Floten, S; Furnary, A; Gately, H; He, GW; Starr, A; Swanson, J; Wood, J; Yang, CO | 1 |
| He, GW; Yang, CQ | 2 |
| Bonnet, PA; Crilley, TK; Wanstall, JC | 1 |
| Gozal, Y; Matot, I | 1 |
| Fakioglu, H; Gelvez, J; Olarte, JL; Soliz, A; Torbati, D; Totapally, BR | 1 |
| Beaver, T; Kirby, DS; Lobato, EB; Naik, B; Urdaneta, F; Willert, JL | 1 |
| Beaver, T; Kirby, DS; Klodell, C; Lobato, EB; Muehlschlegel, J; Sidi, A | 1 |
| Gupte, SA; Rabbani, G; Sarabu, MR; Vijay, V | 1 |
12 other study(ies) available for milrinone and 15-hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic acid
| Article | Year |
|---|---|
Differential vasorelaxant effects of milrinone and amrinone on contractile responses of canine coronary, cerebral, and renal arteries.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Amrinone; Animals; Cerebral Arteries; Coronary Vessels; Dinoprost; Dogs; Female; In Vitro Techniques; Isoproterenol; Male; Milrinone; Muscle Relaxation; Muscle, Smooth, Vascular; Nimodipine; Potassium; Prostaglandin Endoperoxides, Synthetic; Pyridones; Renal Artery; Sodium Nitrite | 1989 |
Effect of milrinone in human platelet shape change, aggregation and thromboxane A2 synthesis: an in vitro study.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Arachidonic Acid; Blood Platelets; Calcimycin; Cells, Cultured; Humans; Indomethacin; Milrinone; Platelet Aggregation; Platelet Aggregation Inhibitors; Prostaglandin Endoperoxides, Synthetic; Pyridones; Serotonin; Thromboxane A2 | 1993 |
The in vitro effects of phosphodiesterase inhibitors on the human internal mammary artery.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Amrinone; Cyclic AMP; Dose-Response Relationship, Drug; Enoximone; Humans; Mammary Arteries; Milrinone; Norepinephrine; Papaverine; Phosphodiesterase Inhibitors; Prostaglandin Endoperoxides, Synthetic; Pyridones; Thromboxane A2; Vasoconstriction; Vasoconstrictor Agents; Vasodilator Agents | 1996 |
Potential greater than additive vasorelaxant actions of milrinone and nitroglycerin on human conduit arteries.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Female; Humans; In Vitro Techniques; Male; Mammary Arteries; Milrinone; Nitroglycerin; Phosphodiesterase Inhibitors; Potassium; Prostaglandin Endoperoxides, Synthetic; Pyridones; Thromboxane A2; Vasoconstrictor Agents; Vasodilator Agents | 1996 |
Inhibition of vasoconstriction by phosphodiesterase III inhibitor milrinone in human conduit arteries used as coronary bypass grafts.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; 3',5'-Cyclic-AMP Phosphodiesterases; Arteries; Cardiovascular Agents; Coronary Artery Bypass; Cyclic Nucleotide Phosphodiesterases, Type 3; Endothelin-1; Female; Humans; In Vitro Techniques; Male; Milrinone; Phenylephrine; Phosphodiesterase Inhibitors; Prostaglandin Endoperoxides, Synthetic; Pyridones; Thromboxane A2; Vasoconstriction; Vasoconstrictor Agents | 1996 |
Vasorelaxant effects of SCA40 (a phosphodiesterase III inhibitor) in pulmonary vascular preparations in rats.
Topics: 1-Methyl-3-isobutylxanthine; 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Cyclic Nucleotide Phosphodiesterases, Type 3; Guinea Pigs; Imidazoles; Male; Milrinone; Muscle, Smooth, Vascular; Parasympatholytics; Phosphodiesterase Inhibitors; Potassium Channel Blockers; Pulmonary Artery; Pyrazines; Pyridones; Rats; Rats, Wistar; Trachea; Vasodilation; Vasodilator Agents | 1998 |
Vasorelaxant effect of phosphodiesterase-inhibitor milrinone in the human radial artery used as coronary bypass graft.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; 3',5'-Cyclic-AMP Phosphodiesterases; Coronary Artery Bypass; Cyclic Nucleotide Phosphodiesterases, Type 3; Humans; In Vitro Techniques; Middle Aged; Milrinone; Muscle, Smooth, Vascular; Phenylephrine; Phosphodiesterase Inhibitors; Potassium; Radial Artery; Vasoconstrictor Agents; Vasodilation | 2000 |
Pulmonary responses to selective phosphodiesterase-5 and phosphodiesterase-3 inhibitors.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; 3',5'-Cyclic-AMP Phosphodiesterases; 3',5'-Cyclic-GMP Phosphodiesterases; Analysis of Variance; Animals; Cats; Cyclic Nucleotide Phosphodiesterases, Type 3; Cyclic Nucleotide Phosphodiesterases, Type 5; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Hypertension, Pulmonary; Infusions, Intravenous; Injections, Intralesional; Male; Milrinone; Phosphoric Diester Hydrolases; Probability; Pulmonary Circulation; Purinones; Random Allocation; Risk Factors; Sensitivity and Specificity; Vascular Resistance | 2004 |
Effect of aerosolized milrinone during drug-induced pulmonary hypertension in lambs.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Aerosols; Animals; Hemodynamics; Hypertension, Pulmonary; Infusions, Intravenous; Milrinone; Pulmonary Gas Exchange; Sheep; Vasoconstrictor Agents; Vasodilator Agents | 2004 |
Effects of a new phosphodiesterase enzyme type V inhibitor (UK 343-664) versus milrinone in a porcine model of acute pulmonary hypertension.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; 3',5'-Cyclic-GMP Phosphodiesterases; Acute Disease; Animals; Blood Pressure; Cyclic Nucleotide Phosphodiesterases, Type 5; Drug Evaluation, Preclinical; Hemodynamics; Hypertension, Pulmonary; Milrinone; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Piperazines; Pyrimidinones; Random Allocation; Sus scrofa; Vasodilator Agents | 2004 |
Treatment with phosphodiesterase inhibitors type III and V: milrinone and sildenafil is an effective combination during thromboxane-induced acute pulmonary hypertension.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; 3',5'-Cyclic-AMP Phosphodiesterases; Acute Disease; Animals; Cyclic Nucleotide Phosphodiesterases, Type 3; Cyclic Nucleotide Phosphodiesterases, Type 4; Disease Models, Animal; Drug Evaluation; Drug Therapy, Combination; Hemodynamics; Hypertension, Pulmonary; Milrinone; Phosphodiesterase Inhibitors; Piperazines; Purines; Sildenafil Citrate; Sulfones; Swine; Vascular Resistance; Vasoconstrictor Agents; Vasodilator Agents | 2006 |
Regulation of human internal mammary and radial artery contraction by extracellular and intracellular calcium channels and cyclic adenosine 3', 5' monophosphate.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adenylyl Cyclases; Calcium; Calcium Channels; Colforsin; Cyclic AMP; Cyclic GMP; Extracellular Fluid; Humans; In Vitro Techniques; Intracellular Fluid; Isoproterenol; Mammary Arteries; Milrinone; Phenylephrine; Potassium Chloride; Radial Artery; Signal Transduction; Vasoconstriction; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents | 2007 |